Editöre Mektup

The Future of Innovative Drug Discovery: Integrating Dual Inhibition and Artificial Intelligence

Cilt: 1 Sayı: 1 10 Ekim 2024
PDF İndir
TR EN

The Future of Innovative Drug Discovery: Integrating Dual Inhibition and Artificial Intelligence

Öz

The field of drug discovery is undergoing transformative changes driven by technological advancements and a deeper understanding of biological systems. This editorial discusses the future directions and potential of innovative drug discovery, emphasizing the need for strategic approaches amidst economic constraints and industry-academia collaboration challenges. Key topics include the importance of affordable, effective drugs with minimal side effects, the role of computer-based methods like molecular docking and QSAR, and the impact of big data and artificial intelligence in accelerating drug development processes. Highlighting dual-target compounds, the editorial explores their potential in treating complex diseases by targeting multiple biological pathways. The integration of AI and dual-target strategies promises significant advancements in drug discovery, offering new avenues for effective and safer therapies.

Anahtar Kelimeler

Kaynakça

  1. Guo, Y., Zou, Y., Chen, Y., Deng, D., Zhang, Z., Liu, K., Tang, M., Yang, T., Fu, S., Zhang, C., Si, W., Ma, Z., Zhang, S., Peng, B., Xu, D., & Chen, L. (2023). Design, synthesis and biological evaluation of purine-based derivatives as novel JAK2/BRD4 (BD2) dual target inhibitors. Bioorganic Chemistry, 132, 106386.
  2. Masson, P., & Mukhametgalieva, A. R. (2023). Partial Reversible Inhibition of Enzymes and Its Metabolic and Pharmaco-Toxicological Implications. International Journal of Molecular Sciences, 24(16), 12973.

Ayrıntılar

Birincil Dil

İngilizce

Konular

Farmasotik Kimya

Bölüm

Editöre Mektup

Yayımlanma Tarihi

10 Ekim 2024

Gönderilme Tarihi

6 Ağustos 2024

Kabul Tarihi

15 Ağustos 2024

Yayımlandığı Sayı

Yıl 2024 Cilt: 1 Sayı: 1

Kaynak Göster

APA
Yücel, M. A., & Algül, Ö. (2024). The Future of Innovative Drug Discovery: Integrating Dual Inhibition and Artificial Intelligence. Erzincan Binali Yıldırım Üniversitesi Sağlık Bilimleri Enstitüsü Dergisi, 1(1), 1-3. https://izlik.org/JA57WG63DM
AMA
1.Yücel MA, Algül Ö. The Future of Innovative Drug Discovery: Integrating Dual Inhibition and Artificial Intelligence. EBYÜSBED. 2024;1(1):1-3. https://izlik.org/JA57WG63DM
Chicago
Yücel, Mehmet Ali, ve Öztekin Algül. 2024. “The Future of Innovative Drug Discovery: Integrating Dual Inhibition and Artificial Intelligence”. Erzincan Binali Yıldırım Üniversitesi Sağlık Bilimleri Enstitüsü Dergisi 1 (1): 1-3. https://izlik.org/JA57WG63DM.
EndNote
Yücel MA, Algül Ö (01 Ekim 2024) The Future of Innovative Drug Discovery: Integrating Dual Inhibition and Artificial Intelligence. Erzincan Binali Yıldırım Üniversitesi Sağlık Bilimleri Enstitüsü Dergisi 1 1 1–3.
IEEE
[1]M. A. Yücel ve Ö. Algül, “The Future of Innovative Drug Discovery: Integrating Dual Inhibition and Artificial Intelligence”, EBYÜSBED, c. 1, sy 1, ss. 1–3, Eki. 2024, [çevrimiçi]. Erişim adresi: https://izlik.org/JA57WG63DM
ISNAD
Yücel, Mehmet Ali - Algül, Öztekin. “The Future of Innovative Drug Discovery: Integrating Dual Inhibition and Artificial Intelligence”. Erzincan Binali Yıldırım Üniversitesi Sağlık Bilimleri Enstitüsü Dergisi 1/1 (01 Ekim 2024): 1-3. https://izlik.org/JA57WG63DM.
JAMA
1.Yücel MA, Algül Ö. The Future of Innovative Drug Discovery: Integrating Dual Inhibition and Artificial Intelligence. EBYÜSBED. 2024;1:1–3.
MLA
Yücel, Mehmet Ali, ve Öztekin Algül. “The Future of Innovative Drug Discovery: Integrating Dual Inhibition and Artificial Intelligence”. Erzincan Binali Yıldırım Üniversitesi Sağlık Bilimleri Enstitüsü Dergisi, c. 1, sy 1, Ekim 2024, ss. 1-3, https://izlik.org/JA57WG63DM.
Vancouver
1.Mehmet Ali Yücel, Öztekin Algül. The Future of Innovative Drug Discovery: Integrating Dual Inhibition and Artificial Intelligence. EBYÜSBED [Internet]. 01 Ekim 2024;1(1):1-3. Erişim adresi: https://izlik.org/JA57WG63DM